2,5-Dioxopyrrolidin-1-yl 4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxylate, 95.0%, 50g

1-(4-Hydroxyphenyl)-2-methoxyethanone, 95.0%, 5g

3-(3-Methylpyrrolidin-3-yl)pyridine, 95%, 100mg

4-Amino-3-ethylbenzoic acid, 95.0%, 250mg

1-Bromo-2,4-difluorobenzene, 98.00%, 5g

anti-Vimentin mouse monoclonal, VIM 3B4, 1 ml

5-(1H-Imidazol-1-yl)-2-pyridinamine, 95%, 5g

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(4-methylphenyl)prop-2-en-1-one, 95.0%, 2g

Decyl 4-hydroxybenzoate, 95.0%, 250mg

Ethyl bicyclo[2.2.1]hept-5-ene-2-carboxylate, 98%, 25g

(3R,4R)-4-AMINO-1-[[4-[(3-METHOXYPHENYL)AMINO]PYRROLO[2,1-F][1,2,4]TRIAZIN-5-YL]METHYL]PIPERIDIN-3-OL, 95.0%, 50mg

3,5-Dimethyl-1H-pyrrole-2-carboxylic acidethyl ester, 97.0%, 500g

tert-Butyl ((1S,3S)-3-hydroxycyclopentyl)carbamate, 95.0%, 10g